Fibronectin enhances in vitro lipopolysaccharide priming of polymorphonuclear leukocytes

Blood

Volumn 89, Issue 11, 1997, Pages 4182-4189

  Bortolussi, Robert ^a,b   Rajaraman, Kausalya ^a   Qing, Gefei ^a   Rajaraman, Rengaswami ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK Children's Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; FIBRONECTIN; HUMORAL ANTIBODY;

ARTICLE; BACTERIAL INFECTION; DOSE RESPONSE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; NEWBORN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030904729     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.4182     Document Type: Article

References (54)

1. Ferrieri P: Neonatal susceptibility and immunity to major bacterial pathogens. Rev Infect Dis 12:S394, 1990 (suppl)
2. Hill HR: Biochemical, tructural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 22:375, 1987
3. Masuda K, Kinoshita Y, Kobayashi Y: Heterogenecity of Fc receptor expression in chemotaxis and adherence of neonatal neutrophils. Pediatr Res 25:6. 1989
4. Noya FJD, Rench MA, Garcia-Prats JA, Jones TM, Baker CJ: Disposition of an immunoglobulin intravenous preparation in very low birth weight neonates. J Pediatr 112:278, 1988
5. Bruce MC, Baley JE, Medvik KA, Berger M: Impaired surface membrane expression of C3bi but not C3b receptors on neonatal neutrophils. Pediatr Res 21:306, 1987
6. Hill HR, Augustine NH, Jaffe HS: Human recombinant interferon γ enhances neonatal polymorphonuclear leukocyte activation and movement, and increases free intracellular calcium. J Exp Med 173:767, 1991
7. Wilson CB: Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 108:1, 1986
8. Baley JE, Bruce M, Stork EK, Klinger JD, Medvik K, Shurin S: Granulocyte transfusions in septic adult and newborn rats: Distribution of granulocytes and effect on peripheral blood and bone marrow. J Clin Lab Clin Med 115:283, 1990
9. Chin T, Toy C, Vandeven C, Cairo MS: Lymphokine-activated killer cytotoxicity in neonatal mononuclear cells: In vitro responses to tumor cell lines from pediatrie solid tumors. Pediatr Res 26:156, 1989
10. Strauss RG, Levy GJ, Sotelo-Avila C, Albanese MA, Hume H, Schloz L, Blazina J, Werner A, Barrasso C, Blanchette V, Warkentin PI, Pepkowitz S, Mauer AM, Hines D: National survey of neonatal transfusion practices:II. Blood component therapy. Pediatrics 91:530, 1993
11. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MAJ: Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. J Immunol 135:2069, 1985
12. Ferrante A, Nandoskar M, Walz A, Goh DHB, Kowanko IC: Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol 86:82, 1988
13. Ferrante A, Hauptmann B, Seckinger P, Dayer J-M: Inhibition of tumour necrosis factor alpha (TNF-α)-induced neutrophil respiratory burst by a TNF inhibitor. Immunol 72:440, 1991
14. Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mori M, Fukushima M: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962, 1990
15. Aida Y, Pabst MJ: Priming of neutrophils by lipopolysaccharide for enhanced release of Superoxide. J Immunol 145:3017, 1990
16. Barbour AG, Allred CD, Solberg CO, Hill HR: Chemiluminescence by polymorphonuclear leukocytes from patients with active bacterial infection. J Infect Dis 141:14, 1980
17. McCarthy JP, Bodroghy RS, Jahrling PB, Sobocinski PZ: Differential alterations in host peripheral polymorphonuclear leukocyte chemiluminescence during the course of bacterial and viral infections. Infect Immun 30:821, 1980
18. Vosbeck K, Tobias P, Mueller H, Allen RA, Arfors K, Ulevitch RJ, Sklar LA: Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J Leukoc Biol 47:97, 1990
19. Schopf RE, Keller R, Rehder M, Benes P, Kallinowski F, Vaupel P: TNFα primes polymorphonuclear leukocytes for an enhanced respiratory burst to a similar extent as bacterial lipopolysaccharide. J Invest Dermatol 95:216S, 1990 (suppl)
20. Tobias PS, Soldau K, Ulevitch RJ: Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 264:10867, 1989
21. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431, 1990
22. Wright SD, Tobias PS, Ulevitch RJ, Ramos RA: Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 170:1231, 1989
23. Tobias PS, Soldau K, Ulevitch RJ: Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164:777, 1986
24. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ: Structure and function of lipopolysaccharide binding protein. Science 249:1429, 1990
25. Weingarten R, Sklar LA, Mathison JC, Omidi S, Ainsworth T, Simon S, Ulevitch RJ, Tobias PS: Interactions of lipopolysaccharide with neutrophils in blood via CD14. J Leukoc Biol 53:518, 1993
26. Pugin J, Schürer-Maly C-C, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS: Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 90:2744, 1993
27. Ulevitch RJ, Tobias PS: Recognition of endotoxin by cells leading to transmembrane signaling. Curr Op Immunol 6:125, 1994
28. Wright SD, Ramos RA, Patel M, Miller DS: Septin: A factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med 176:719, 1992
29. Lee J-D, Kravchenko V, Kirkland TN, Han J, Mackman N, Moriarity A, Leturcq D, Tobias PS, Ulevitch RJ: Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci USA 90:9930, 1993
30. Howard TH, Wang D, Berkow RL: Lipopolysaccharide modulates chemotactic peptide-induced actin polymerization in neutrophils. J Leukoc Biol 47:13, 1990
31. Norgauer J, Eberle M, Fay SP, Lemke HD, Sklar LA: Kinetics of N-formyl peptide receptor up-regulation during stimulation in human neutrophils. J Immunol 146:975, 1991
32. Qing G, Rajaraman K, Bortolussi R: Diminished priming of neonatal polymorphonuclear leukocytes by lipopolysaccharide is associated with reduced CD14 expression. Infect Immun 63:248, 1995
33. Bortolussi R, Howlett S, Rajaraman K, Halperin S: Deficient priming activity of newborn cord blood-derived polymorphonuclear neutrophilic granulocytes with lipopolysaccharide and tumor necrosis factor-α triggered with formyl-methionyl-leucyl-phenylalanine. Pediatr Res 34:243, 1993
34. Qing G, Howlett S, Bortolussi R: Lipopolysaccharide (LPS) binding proteins on polymorphonuclear leukocytes (PMN): Comparison of adult and neonatal cells. Infect Immun 64:4638, 1996
35. Rajaraman R, Sunkara SP, Rao PN: Morphological reverse transformation of Chinese hamster ovary (CHO) cells and surface fibronectin. Cell Biol Int Rep 4:897, 1980
36. McPhail LC, Strum SL, Leone PA, Sozzani S: The Neutrophil Respiratory Burst Mechanism, in Coffey RG (ed): Granulocyte responses to cytokines: Basic and clinical research. New York, NY, Dekker, 1993, p 47
37. Gyllenhammar H: Lucigenin chemiluminescence in the assessment of neutrophil Superoxide production. J Immunol Methods 97:209, 1987
38. Engvall E, Ruoslahti E: Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 26:451, 1977
39. Rajaraman R, MacSween JM, Murdoch CA: Exogenous fibronectin requirement for adhesion by neoplastic human cells. Exp Cell Biol 5:9, 1983
40. Scott DL, Bedford PA, Walton KW: The preparation of plasma fibronectin antigen and antiserum. J Immunol Methods 43:29, 1981
41. Ruoslahti E, Vuento M, Engvall E: Interaction of fibronectin with antibodies and collagen in radioimmunoassay. Biochim Biophys Acta 534:210, 1978
42. Martin TR, Mathison JC, Tobias PS, Leturcq DJ, Moriarty AM, Maunder RJ, Ulevitch RJ: Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. J Clin Invest 90:2209, 1992
43. Polin RA: Role of fibronectin in diseases of newborn infants and children. Rev Infect Dis 12:S428, 1990 (suppl)
44. Morrison DC, Lei M-G, Kirikae T, Chen T-Y: Endotoxin receptors in mammalian cells. Immunobiology 187:212, 1993
45. Yasui K, Komiyama A, Molski TF, Sha'afi RT: Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of Superoxide by lipopolysaccharide: Possible mechanism of these actions. Infect Immun 62:922, 1994
46. Doran JE, Mansberger AR, Edmondson HT, Reese AC: Cold insoluble globulin and heparin interactions in phagocytosis by macrophage monolayers: Mechanism of heparin enhancement. J Reticulo Soc 29:285, 1981
47. Dapino P, Dallegri F, Ottonello L, Sacchetti C: Induction of neutrophil respiratory burst by tumour necrosis factor-alpha: priming effect of solid-phase fibronectin and intervention of CD11b-CD18 integrins. Clin Exp Immunol 94:533, 1993
48. Everitt EA, Malik AB, Hendey B: Fibronectin enhances the migration rate of human neutrophils in vitro. J Leukoc Biol 60:199, 1996
49. Rajaraman R: Molecular mechanisms of cell adhesion: Recent advances, in Malhotra SK (ed): Advances in Structural Biology. Greenwich, CT, JAI, 1991, p 117
50. Dyke MP, Forsyth KD: Decreased plasma fibronectin concentrations in preterm infants with septicaemia. Arch Dis Child 68:557, 1993
51. Yang KD, Augustine NH, Gonzalez LA, Bohnsack JF, Hill HR: Effects of fibronectin on the interaction of polymorphonuclear leukocytes with unopsonized and antibody-opsonized bacteria. J Infect Dis 158:823, 1988
52. Hill HR, Augustine NH, Williams PA, Brown EJ, Bohnsack JF: Mechanism of fibronectin enhancement of group B streptococcal phagocytosis by human neutrophils and culture-derived macrophages. Infect Immun 61:2334, 1993
53. Hill HR, Shigeoka AO, Augustine NH, Pritchard D, Lundblad JL, Schwartz RS: Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci. J Exp Med 159:1618, 1984
54. Köttgen E, Hell B, Müller C, Kainer F, Tauber R: Developmental changes in the glycosylation and binding properties of human fibronectins. Biol Chem Hoppe Seyler 370:1285, 1989